Literature DB >> 15258701

Antibody-based cancer therapies: back to "polyclonals"?

Giovanni Paganelli, Rita De Santis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15258701     DOI： 10.1007/s00259-004-1627-5

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  22 in total

1.  Monoclonal antibody therapy for resected Dukes' C colorectal cancer: seven-year outcome of a multicenter randomized trial.

Authors:  G Riethmüller; E Holz; G Schlimok; W Schmiegel; R Raab; K Höffken; R Gruber; I Funke; H Pichlmaier; H Hirche; P Buggisch; J Witte; R Pichlmayr
Journal:  J Clin Oncol       Date:  1998-05       Impact factor: 44.544

Review 2.  Pretargeted radioimmunotherapy of cancer: progress step by step.

Authors:  Otto C Boerman; Frank G van Schaijk; Wim J G Oyen; Frans H M Corstens
Journal:  J Nucl Med       Date:  2003-03       Impact factor: 10.057

3.  Antibody-guided three-step therapy for high grade glioma with yttrium-90 biotin.

Authors:  G Paganelli; C Grana; M Chinol; M Cremonesi; C De Cicco; F De Braud; C Robertson; S Zurrida; C Casadio; S Zoboli; A G Siccardi; U Veronesi
Journal:  Eur J Nucl Med       Date:  1999-04

4.  A comparative evaluation of conventional and pretargeted radioimmunotherapy of CD20-expressing lymphoma xenografts.

Authors:  O W Press; M Corcoran; K Subbiah; D K Hamlin; D S Wilbur; T Johnson; L Theodore; E Yau; R Mallett; D L Meyer; D Axworthy
Journal:  Blood       Date:  2001-10-15       Impact factor: 22.113

5.  Combined treatment of advanced oropharyngeal cancer with external radiotherapy and three-step radioimmunotherapy.

Authors:  G Paganelli; R Orecchia; B Jereczek-Fossa; C Grana; M Cremonesi; F De Braud; N Tradati; M Chinol
Journal:  Eur J Nucl Med       Date:  1998-09

6.  Gene expression profiles of primary breast tumors maintained in distant metastases.

Authors:  Britta Weigelt; Annuska M Glas; Lodewyk F A Wessels; Anke T Witteveen; Johannes L Peterse; Laura J van't Veer
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-09       Impact factor: 11.205

7.  Single-chain Fv-streptavidin substantially improved therapeutic index in multistep targeting directed at disialoganglioside GD2.

Authors:  Nai-Kong V Cheung; Shakeel Modak; Yukang Lin; Hongfen Guo; Pat Zanzonico; John Chung; Yuting Zuo; James Sanderson; Sibylle Wilbert; Louis J Theodore; Donald B Axworthy; Steven M Larson
Journal:  J Nucl Med       Date:  2004-05       Impact factor: 10.057

8.  Autocrine pathways of the vascular endothelial growth factor (VEGF) in glioblastoma multiforme: clinical relevance of radiation-induced increase of VEGF levels.

Authors:  Hans-Herbert Steiner; Sybille Karcher; Margareta M Mueller; Emilios Nalbantis; Stefan Kunze; Christel Herold-Mende
Journal:  J Neurooncol       Date:  2004-01       Impact factor: 4.130

9.  Pretargeted adjuvant radioimmunotherapy with yttrium-90-biotin in malignant glioma patients: a pilot study.

Authors:  C Grana; M Chinol; C Robertson; C Mazzetta; M Bartolomei; C De Cicco; M Fiorenza; M Gatti; P Caliceti; G Paganelli
Journal:  Br J Cancer       Date:  2002-01-21       Impact factor: 7.640

10.  Prognostic value of VEGF in human pancreatic ductal adenocarcinoma.

Authors:  Yun Jeong Lim; Jong Kyun Lee; Cheol Keun Park; Sang Yong Song; Woo Young Jang; Hye Young Ha; Dong Il Park; Kyu Taek Lee; Seung Woon Paik; Byung Chul Yoo; Jong Chul Rhee
Journal:  Korean J Intern Med       Date:  2004-03       Impact factor: 2.884
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.